Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Douglas Emmett, Inc. (DEI) Going to Burn These Hedge Funds?

Page 1 of 2

At the moment, there are tons of indicators market participants can use to analyze their holdings. Two of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best money managers can outperform the S&P 500 by a solid margin (see just how much).

Equally as key, positive insider trading activity is a second way to analyze the stock market universe. Just as you’d expect, there are lots of incentives for an executive to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Many empirical studies have demonstrated the market-beating potential of this method if investors know what to do (learn more here).

Douglas Emmett, Inc. (NYSE:DEI)

Keeping this in mind, it’s important to examine the latest info about Douglas Emmett, Inc. (NYSE:DEI).

What does the smart money think about Douglas Emmett, Inc. (NYSE:DEI)?

At Q2’s end, a total of 7 of the hedge funds we track were long in this stock, a change of -13% from the first quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes substantially.

When using filings from the hedgies we track, AEW Capital Management, managed by Jeffrey Furber, holds the most valuable position in Douglas Emmett, Inc. (NYSE:DEI). AEW Capital Management has a $14 million position in the stock, comprising 0.4% of its 13F portfolio. Coming in second is Elm Ridge Capital, managed by Ron Gutfleish, which held a $7.6 million position; 0.9% of its 13F portfolio is allocated to the stock. Some other hedge funds with similar optimism include Ken Griffin’s Citadel Investment Group, Cliff Asness’s AQR Capital Management and Robert B. Gillam’s McKinley Capital Management.

Since Douglas Emmett, Inc. (NYSE:DEI) has experienced dropping sentiment from the entirety of the hedge funds we track, it’s easy to see that there were a few money managers that decided to sell off their positions entirely heading into Q2. At the top of the heap, Jim Simons’s Renaissance Technologies sold off the biggest investment of the “upper crust” of funds we key on, worth an estimated $4.9 million in stock, and Israel Englander of Millennium Management was right behind this move, as the fund dumped about $1 million worth. These bearish behaviors are important to note, as total hedge fund interest was cut by 1 funds heading into Q2.

What do corporate executives and insiders think about Douglas Emmett, Inc. (NYSE:DEI)?

Legal insider trading, particularly when it’s bullish, is most useful when the primary stock in question has seen transactions within the past six months. Over the last 180-day time period, Douglas Emmett, Inc. (NYSE:DEI) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Douglas Emmett, Inc. (NYSE:DEI). These stocks are National Retail Properties, Inc. (NYSE:NNN), Chimera Investment Corporation (NYSE:CIM), MFA Financial, Inc. (NYSE:MFA), Starwood Property Trust, Inc. (NYSE:STWD), and Retail Properties of America Inc (NYSE:RPAI). All of these stocks are in the reit – diversified industry and their market caps resemble DEI’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!